[go: up one dir, main page]

CN111320767B - A preparation method of thixotropic hydrogel for 3D bioprinting - Google Patents

A preparation method of thixotropic hydrogel for 3D bioprinting Download PDF

Info

Publication number
CN111320767B
CN111320767B CN202010144190.XA CN202010144190A CN111320767B CN 111320767 B CN111320767 B CN 111320767B CN 202010144190 A CN202010144190 A CN 202010144190A CN 111320767 B CN111320767 B CN 111320767B
Authority
CN
China
Prior art keywords
solution
polyphenol
protein
powder
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010144190.XA
Other languages
Chinese (zh)
Other versions
CN111320767A (en
Inventor
屈树新
崔荣伟
熊雄
陈园园
李茂红
王生龙
方麒博
翁杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest Jiaotong University
Original Assignee
Southwest Jiaotong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest Jiaotong University filed Critical Southwest Jiaotong University
Priority to CN202010144190.XA priority Critical patent/CN111320767B/en
Publication of CN111320767A publication Critical patent/CN111320767A/en
Application granted granted Critical
Publication of CN111320767B publication Critical patent/CN111320767B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10Processes of additive manufacturing
    • B29C64/106Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08HDERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00Macromolecular products derived from proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/02Dextran; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/04Alginic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/12Agar-agar; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00Characterised by the use of proteins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/02Dextran; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/04Alginic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/12Agar-agar; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2489/00Characterised by the use of proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Manufacturing & Machinery (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Optics & Photonics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Mechanical Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Materials For Medical Uses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the steps of: A. dissolving protein powder, polyphenol powder and polysaccharide powder in deionized water to obtain protein solutions with the concentration of 3.0-10.0wt.% respectively; a polyphenol solution having a concentration of 0.10-0.75 wt.%; a polysaccharide solution having a concentration of 2.0-8.0 wt.%; B. adding the protein solution and the polyphenol solution prepared in the step A into a reactor according to the proportion of 1-10 to 1, and magnetically stirring for 1-3 hours under the water bath condition of 40-50 ℃ to obtain a protein-polyphenol binary compound solution; C. and (3) adding the polysaccharide solution into the compound solution obtained in the step (B), adding the polysaccharide solution into the compound solution in a volume ratio of 2-4. The hydrogel prepared by the method is used as a 3D biological printing material, and has excellent biocompatibility and injectability.

Description

一种用于3D生物打印的可触变性水凝胶的制备方法A preparation method of thixotropic hydrogel for 3D bioprinting

技术领域technical field

本发明涉及一种用于3D生物打印的可触变性水凝胶的制备方法。The invention relates to a preparation method of thixotropic hydrogel for 3D bioprinting.

背景技术Background technique

3D生物打印是基于医学图像转换设计的模型,在计算机精确控制下,将生物打印“墨水”(生物相容材料和细胞)层层打印成型,体外构建出类似于体内的三维结构与微环境。3D生物打印得到的三维结构与微环境提供了一个仿生的三维细胞培养条件,其中的细胞经过合适的培养,最终培育成功能化的、用于体内替换和再生以及体外药物筛选和疾病研究的类组织/器官。目前常见的3D生物打印方法有喷墨打印型、激光辅助型和挤出型三种(Li J,Chen M,Fan X,et al.Recent advances in bioprinting techniques:approaches,applications and future prospects.Journal of TranslationalMedicine,2016,14(1):271.)。其中,挤出型3D生物打印是利用机械力或者空气压力将“生物墨水”(通常为携载着细胞的水凝胶材料)从喷头挤出,从而构建三维的结构(Zhang Z,Wang B,Hui D,et al.3D bioprinting of soft materials-based regenerativevascular structures and tissues.Composites Part B:Engineering,2017.),其具有易操作、经济、条件温和及打印较高密度细胞等特点;同时,可避免使用高温和高压等苛刻的工作条件。3D bioprinting is a model based on medical image conversion design. Under the precise control of the computer, the bioprinting "ink" (biocompatible materials and cells) is printed layer by layer, and a three-dimensional structure and microenvironment similar to that in the body is constructed in vitro. The three-dimensional structure and microenvironment obtained by 3D bioprinting provide a bionic three-dimensional cell culture condition, in which the cells are properly cultured and finally cultivated into functional species for in vivo replacement and regeneration as well as in vitro drug screening and disease research. Tissue/Organ. At present, there are three common 3D bioprinting methods: inkjet printing, laser-assisted and extrusion (Li J, Chen M, Fan X, et al.Recent advances in bioprinting techniques: approaches, applications and future prospects. Journal of Translational Medicine, 2016, 14(1): 271.). Among them, extrusion-type 3D bioprinting uses mechanical force or air pressure to extrude "bio-ink" (usually a hydrogel material carrying cells) from a nozzle to construct a three-dimensional structure (Zhang Z, Wang B, Hui D, et al. 3D bioprinting of soft materials-based regenerative vascular structures and tissues. Composites Part B: Engineering, 2017.), which has the characteristics of easy operation, economy, mild conditions and printing higher density cells; at the same time, it can avoid Use harsh working conditions such as high temperature and high pressure.

虽然,挤出式3D生物打印的操作和原理简单,但是挤出式3D生物打印技术对“生物墨水”材料性能要求较高,要求材料具有较好的注射性和成型性,这样才能在较低的机械力作用下使“生物墨水”顺利喷出,并且能够较快的形成形状;同时,还要具有优异的生物相容性,可以对包裹在水凝胶中的细胞实现保护和调控,为细胞提供接近于细胞外基质的三维环境以保证细胞的迁移、生长和分化(N.E.Fedorovich,J.R.De Wijn,A.J.Verbout,J.Alblas,W.J.Dhert,Three-dimensional fiber deposition of cell-laden,viable,patterned constructs for bone tissue printing,Tissue Eng Part A14(1)(2008)127-33)。Although the operation and principle of extrusion-type 3D bioprinting are simple, extrusion-type 3D bioprinting technology has high requirements on the performance of "bio-ink" materials, which require materials to have good injectability and moldability, so that they can be processed at a low temperature. Under the action of strong mechanical force, the "bio-ink" can be ejected smoothly, and can form a shape quickly; at the same time, it must have excellent biocompatibility, which can protect and regulate the cells wrapped in hydrogel. Cells provide a three-dimensional environment close to the extracellular matrix to ensure cell migration, growth and differentiation (N.E.Fedorovich, J.R.De Wijn, A.J.Verbout, J.Alblas, W.J.Dhert, Three-dimensional fiber deposition of cell-laden, viable, patterned constructs for bone tissue printing, Tissue Eng Part A14(1)(2008) 127-33).

“生物墨水”材料想要顺利挤出,并且保护其中包裹的细胞受到尽可能小的剪切力,需要具有较小的粘度;而粘度变小又会使得成型性能严重降低,使得打印的三维结构坍缩。触变性的水凝胶材料可利用其“受力稀化,撤力恢复”的特性有望兼顾成型性与挤出性(You Chen,a Yihan Wang,Qian Yang,et al.A novel thixotropic magnesiumphosphate-based bioink with excellent printability for application in 3Dprinting,journal of materials chemistry B,2018,6,4502-4513),但现有的具有触变性的材料往往为化学合成材料,生物相容性并不优异;且文献所报道的应用于生物医学领域的触变性材料触变后恢复时间较长(You Chen,a Yihan Wang,Qian Yang,et al.Anovelthixotropic magnesium phosphate-based bioink with excellent printability forapplication in 3D printing,journal of materials chemistry B,2018,6,4502-4513),导致打印后成型性较差,难以较快地在打印层上继续打印,限制了其在3D生物打印中的应用。因此,当前3D生物打印的发展迫切需要一种生物相容性好、触变性高(恢复时间快)的“生物墨水”水凝胶材料。If the "bio-ink" material wants to be extruded smoothly and protect the cells wrapped in it from the shear force as small as possible, it needs to have a small viscosity; and the viscosity becomes smaller and the molding performance will be seriously reduced, making the printed three-dimensional structure collapse. Thixotropic hydrogel materials can take advantage of their characteristics of "thinning under force and recovery after force removal" (You Chen, a Yihan Wang, Qian Yang, et al. A novel thixotropic magnesium phosphate-based bioink with excellent printability for application in 3Dprinting, journal of materials chemistry B, 2018, 6, 4502-4513), but the existing thixotropic materials are often chemically synthesized materials, and the biocompatibility is not excellent; and the literature The reported thixotropic materials used in the biomedical field have a long recovery time after thixotropy (You Chen, a Yihan Wang, Qian Yang, et al. Anovelthixotropic magnesium phosphate-based bioink with excellent printability for application in 3D printing, journal of materials chemistry B, 2018, 6, 4502-4513), leading to poor formability after printing, it is difficult to continue printing on the printing layer faster, which limits its application in 3D bioprinting. Therefore, the current development of 3D bioprinting urgently needs a "bioink" hydrogel material with good biocompatibility and high thixotropy (fast recovery time).

发明内容Contents of the invention

本发明的目的是提供一种用于3D生物打印的可触变性水凝胶的制备方法,该方法的工艺简单、制备成本低;制备的可触变性水凝胶用作3D生物打印材料,其注射性能和成型性能好,同时具有优良的生物相容性,打印后的细胞活性高,能够为细胞提供更接近于细胞外基质组分的生长环境,促进组织和器官的再生。The object of the present invention is to provide a kind of preparation method of the thixotropic hydrogel that is used for 3D bioprinting, and the technology of this method is simple, preparation cost is low; The thixotropic hydrogel prepared is used as 3D bioprinting material, and its The injection performance and molding performance are good, and it has excellent biocompatibility. The cell activity after printing is high, which can provide cells with a growth environment closer to the extracellular matrix components and promote the regeneration of tissues and organs.

本发明实现其发明目的所采用的技术方案是,一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:The technical solution adopted by the present invention to realize the purpose of the invention is a preparation method of a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将蛋白质粉末、多酚粉末和多糖粉末各自溶于去离子水中,分别得到浓度为3.0-10.0wt.%的蛋白质溶液;浓度为0.10-0.75wt.%的多酚溶液;浓度为2.0-8.0wt.%的多糖溶液;A, stock solution preparation: protein powder, polyphenol powder and polysaccharide powder are respectively dissolved in deionized water to obtain a protein solution with a concentration of 3.0-10.0wt.%; a polyphenol solution with a concentration of 0.10-0.75wt.%. 2.0-8.0wt.% polysaccharide solution;

B、蛋白质-多酚二元复合物的合成:将A步配置的蛋白质溶液和多酚溶液按照1-10:1的比例加入反应器,并在40-50℃的水浴条件下磁力搅拌1-3h,得到蛋白质-多酚二元复合物溶液;B. Synthesis of protein-polyphenol binary complex: Add the protein solution and polyphenol solution prepared in step A into the reactor at a ratio of 1-10:1, and magnetically stir in a water bath at 40-50°C for 1- 3h, obtain the protein-polyphenol binary complex solution;

C、凝胶的制备:将A步配置的多糖溶液加入到B步的蛋白质-多酚二元复合物溶液中,其中多糖溶液与蛋白质-多酚二元复合物溶液的体积比为2-4:1,在40-50℃的水浴条件下磁力搅拌至溶液颜色均一,且不分层,即得。C. Preparation of gel: Add the polysaccharide solution configured in step A to the protein-polyphenol binary complex solution in step B, wherein the volume ratio of the polysaccharide solution to the protein-polyphenol binary complex solution is 2-4 : 1, under the condition of 40-50 DEG C of water bath, stir magnetically until the color of the solution is uniform without delamination.

本发明的反应原理和机理是:Reaction principle and mechanism of the present invention are:

先将蛋白质溶液和多酚溶液进行水浴反应,多酚溶液中的酚羟基被氧化失去H-后,使得苯环上的空位与蛋白质氨基酸残基中的α-氨基发生共价结合,多酚溶液中未被氧化的酚羟基与蛋白质氨基酸残基的侧链基团中的单原子形成分子间氢键,从而生成蛋白质-多酚二元复合物。First, the protein solution and the polyphenol solution are subjected to a water bath reaction. After the phenolic hydroxyl group in the polyphenol solution is oxidized and loses H- , the vacancy on the benzene ring is covalently bonded to the α-amino group in the amino acid residue of the protein. The polyphenol solution The unoxidized phenolic hydroxyl group in the protein forms an intermolecular hydrogen bond with a single atom in the side chain group of the amino acid residue of the protein, thereby generating a protein-polyphenol binary complex.

再将多糖溶液加入到蛋白质-多酚二元复合物溶液中进行凝胶反应,复合物中的蛋白质氨基酸残基的α-氨基带正电与带负电的多糖的羧基形成静电吸附,得到蛋白质-多酚-多糖基三元复合物水凝胶。Then the polysaccharide solution is added to the protein-polyphenol binary complex solution for gel reaction, the α-amino group of the protein amino acid residue in the complex is positively charged and the carboxyl group of the negatively charged polysaccharide forms electrostatic adsorption, and the protein- Polyphenol-polysaccharide-based ternary complex hydrogels.

本发明的可触变性(蛋白质-多酚-多糖基)水凝胶的使用方法是:The using method of thixotropic (protein-polyphenol-polysaccharide base) hydrogel of the present invention is:

将制备的可触变性水凝胶与细胞配置成生物打印“墨水”,然后将其放置在挤出式3D打印机浆料筒中,进行3D生物打印。打印后的支架模型,放置于细胞培养基中,然后在37℃,5%CO2培养箱中培养,经细胞生长、增殖后,即形成用于体内替换和再生以及体外药物筛选和疾病研究的类组织/器官。The prepared thixotropic hydrogel and cells are configured into a bioprinting "ink", which is then placed in an extrusion 3D printer slurry cartridge for 3D bioprinting. The printed scaffold model is placed in cell culture medium, and then cultured in a 37°C, 5% CO 2 incubator. After cell growth and proliferation, it will be used for in vivo replacement and regeneration, in vitro drug screening and disease research. Tissues/organs.

与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:

一、本发明制备得到的基于蛋白质-多酚-多糖的可触变性水凝胶的触变性,主要来源于蛋白质与多酚间的氢键结合、蛋白质与多糖间的静电相互作用。挤出时,这两种相互作用力受到挤压力而被破坏,水凝胶发生剪切稀化变为溶胶;使其作为3D生物打印材料时,具有优异的注射性,打印所需的挤出力小,对细胞的损伤小、细胞的活性高,能够更好的促进组织和器官的再生。而当外力撤销(挤出后成型)时,组分间会迅速重新形成氢键及发生静电相互作用,恢复为凝胶状态(触变性);使其打印成型后可以长时间地保持凝胶结构的稳定,具有优异的成型性。1. The thixotropy of the protein-polyphenol-polysaccharide-based thixotropic hydrogel prepared in the present invention mainly comes from the hydrogen bonding between protein and polyphenol, and the electrostatic interaction between protein and polysaccharide. During extrusion, these two interaction forces are destroyed by the extrusion force, and the hydrogel undergoes shear thinning and becomes a sol; when it is used as a 3D bioprinting material, it has excellent injectability, and the extrusion required for printing The output is small, the damage to cells is small, the activity of cells is high, and it can better promote the regeneration of tissues and organs. When the external force is removed (molding after extrusion), hydrogen bonds will be quickly re-formed and electrostatic interactions will occur between the components, returning to the gel state (thixotropy); it can maintain the gel structure for a long time after printing stable and has excellent formability.

实验证明,将本发明制得的水凝胶和细胞一起,利用挤出式3D生物打印机,打印成三维组织(器官)支架。打印时的注射压力仅为1N,打印过程流畅、无堵塞喷头和停机现象,打印出的三维支架,结构稳定,无坍塌现象,成型性优异,具有良好的形状保真度。Experiments have proved that the hydrogel prepared by the present invention and cells are printed into a three-dimensional tissue (organ) scaffold by using an extrusion 3D bioprinter. The injection pressure during printing is only 1N, the printing process is smooth, there is no clogging of nozzles and stoppage phenomenon, and the printed three-dimensional scaffold has a stable structure, no collapse phenomenon, excellent formability, and good shape fidelity.

二、本发明的原料为动植物体内本身存在的蛋白质、多酚以及多糖,生物相容性优异。且该三种组分与细胞外基质组分相似,能够更好地为细胞生长提供理想的环境。2. The raw materials of the present invention are proteins, polyphenols and polysaccharides existing in animals and plants, and have excellent biocompatibility. And the three components are similar to the extracellular matrix components, which can better provide an ideal environment for cell growth.

三、制备操作均在常温液态下进行,条件温和、工艺简单、制备成本低。3. The preparation operations are all carried out in liquid state at normal temperature, with mild conditions, simple process and low preparation cost.

进一步,本发明的步骤A的蛋白质可以为明胶、纤维蛋白原、纤维蛋白、丝素蛋白、透明质酸或胶原中的一种或一种以上的混合物。Further, the protein in step A of the present invention may be one or a mixture of gelatin, fibrinogen, fibrin, silk fibroin, hyaluronic acid or collagen.

进一步,本发明的步骤A的多酚为单宁酸、茶多酚、咖啡酸、儿茶素、没食子酸、鞣花酸、熊果苷、花青素中的一种或一种以上的混合物。Further, the polyphenol in step A of the present invention is one or more mixtures of tannic acid, tea polyphenols, caffeic acid, catechin, gallic acid, ellagic acid, arbutin, and anthocyanins .

进一步,本发明的步骤A的多糖为海藻酸钠、壳聚糖、结冷胶、右旋糖酐、琼脂糖或亚麻籽胶。Further, the polysaccharide in step A of the present invention is sodium alginate, chitosan, gellan gum, dextran, agarose or linseed gum.

以上蛋白质粉末、多酚粉末和多糖粉末都为动植物存在的物质,生物相容性高;且三种物质的成分与细胞外基质组分相似,能促进新骨生成,能够更好地为细胞生长提供理想的环境。The above protein powder, polyphenol powder and polysaccharide powder are substances that exist in animals and plants, and have high biocompatibility; and the components of the three substances are similar to the components of the extracellular matrix, which can promote new bone formation and better serve cells. Provides an ideal environment for growth.

下面结合具体实施方式对本发明作进一步地详细说明。The present invention will be further described in detail below in combination with specific embodiments.

具体实施方式detailed description

实施例1Example 1

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将明胶粉末、单宁酸粉末和海藻酸钠粉末各自溶于去离子水中,分别得到浓度为6.0wt.%的明胶溶液;浓度为0.25wt.%的单宁酸溶液;浓度为3.0wt.%的海藻酸钠溶液;A, stock solution preparation: gelatin powder, tannic acid powder and sodium alginate powder are respectively dissolved in deionized water to obtain a gelatin solution with a concentration of 6.0wt.% respectively; a tannic acid solution with a concentration of 0.25wt.%; 3.0wt.% sodium alginate solution;

B、明胶-单宁酸二元复合物的合成:将A步配置的明胶溶液和单宁酸溶液按照1:1的比例加入反应器,并在40℃的水浴条件下磁力搅拌2h,得到明胶-单宁酸二元复合物溶液;B. Synthesis of gelatin-tannic acid binary complex: add the gelatin solution and tannic acid solution prepared in step A into the reactor at a ratio of 1:1, and stir magnetically for 2 hours in a water bath at 40°C to obtain gelatin - tannic acid binary complex solution;

C、凝胶的制备:将A步配置的海藻酸钠溶液加入到B步的明胶-单宁酸二元复合物溶液中,其中海藻酸钠溶液与明胶-单宁酸二元复合物溶液的体积比为3:1,在50℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C, preparation of gel: the sodium alginate solution configured in step A is added to the gelatin-tannic acid binary complex solution of B step, wherein the sodium alginate solution and the gelatin-tannic acid binary complex solution The volume ratio is 3:1, and the color of the magnetically stirred solution is uniform under the condition of a water bath at 50°C, and there is no layering.

实施例2Example 2

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将纤维蛋白原粉末、茶多酚粉末和壳聚糖粉末各自溶于去离子水中,分别得到浓度为3wt.%的纤维蛋白原溶液;浓度为0.10wt.%的茶多酚溶液;浓度为2.0wt.%的壳聚糖溶液;A, stoste preparation: fibrinogen powder, tea polyphenol powder and chitosan powder are respectively dissolved in deionized water, respectively to obtain a concentration of 3wt.% fibrinogen solution; concentration of 0.10wt.% tea polyphenol Solution; concentration is 2.0wt.% chitosan solution;

B、纤维蛋白原-茶多酚二元复合物的合成:将A步配置的纤维蛋白原溶液和茶多酚溶液按照5:1的比例加入反应器,并在45℃的水浴条件下磁力搅拌1h,得到纤维蛋白原-茶多酚二元复合物溶液;B. Synthesis of fibrinogen-tea polyphenol binary complex: add the fibrinogen solution and tea polyphenol solution prepared in step A into the reactor at a ratio of 5:1, and stir magnetically in a water bath at 45°C 1h, obtain the fibrinogen-tea polyphenol binary complex solution;

C、凝胶的制备:将A步配置的壳聚糖溶液加入到B步的纤维蛋白原-茶多酚二元复合物溶液中,其中壳聚糖溶液与纤维蛋白原-茶多酚二元复合物溶液的体积比为2:1,在45℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C. Preparation of gel: Add the chitosan solution configured in step A to the fibrinogen-tea polyphenol binary complex solution in step B, wherein the chitosan solution and the fibrinogen-tea polyphenol binary The volume ratio of the complex solution is 2:1, and the color of the solution is uniform under magnetic stirring under the condition of a water bath at 45° C. without stratification.

实施例3Example 3

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将纤维蛋白粉末、咖啡酸粉末和结冷胶粉末各自溶于去离子水中,分别得到浓度为10.0wt.%的纤维蛋白溶液;浓度为0.75wt.%的咖啡酸溶液;浓度为8.0wt.%的结冷胶溶液;A, stock solution preparation: respectively dissolve fibrin powder, caffeic acid powder and gellan gum powder in deionized water to obtain respectively a fibrin solution with a concentration of 10.0wt.%; a caffeic acid solution with a concentration of 0.75wt.%; 8.0wt.% gellan gum solution;

B、纤维蛋白-咖啡酸二元复合物的合成:将A步配置的纤维蛋白溶液和咖啡酸溶液按照10:1的比例加入反应器,并在50℃的水浴条件下磁力搅拌3h,得到纤维蛋白-咖啡酸二元复合物溶液;B. Synthesis of fibrin-caffeic acid binary complex: Add the fibrin solution and caffeic acid solution prepared in step A into the reactor at a ratio of 10:1, and stir magnetically for 3 hours in a water bath at 50°C to obtain fibers Protein-caffeic acid binary complex solution;

C、凝胶的制备:将A步配置的结冷胶溶液加入到B步的纤维蛋白-咖啡酸二元复合物溶液中,其中结冷胶溶液与纤维蛋白-咖啡酸二元复合物溶液的体积比为4:1,在40℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C, preparation of gel: the gellan gum solution configured in step A is added to the fibrin-caffeic acid binary complex solution of B step, wherein the gellan gum solution and the fibrin-caffeic acid binary complex solution The volume ratio is 4:1, and the color of the magnetically stirred solution is uniform under the condition of a water bath at 40°C, and there is no layering.

实施例4Example 4

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将丝素蛋白粉末、儿茶素粉末和右旋糖酐粉末各自溶于去离子水中,分别得到浓度为7wt.%的丝素蛋白溶液;浓度为0.50wt.%的儿茶素溶液;浓度为5.0wt.%的右旋糖酐溶液;A. Stock solution preparation: dissolve silk fibroin powder, catechin powder and dextran powder in deionized water respectively to obtain a silk fibroin solution with a concentration of 7wt.% and a catechin solution with a concentration of 0.50wt.%. Concentration is the dextran solution of 5.0wt.%.

B、丝素蛋白-儿茶素二元复合物的合成:将A步配置的丝素蛋白溶液和儿茶素溶液按照4:1的比例加入反应器,并在47℃的水浴条件下磁力搅拌2.5h,得到丝素蛋白-儿茶素二元复合物溶液;B. Synthesis of silk fibroin-catechin binary complex: Add the silk fibroin solution and catechin solution prepared in step A into the reactor at a ratio of 4:1, and stir magnetically under the condition of a water bath at 47°C 2.5h, obtain the silk fibroin-catechin binary complex solution;

C、凝胶的制备:将A步配置的右旋糖酐溶液加入到B步的丝素蛋白-儿茶素二元复合物溶液中,其中右旋糖酐溶液与丝素蛋白-儿茶素二元复合物溶液的体积比为4:1,在46℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C. Preparation of gel: Add the dextran solution configured in step A to the silk fibroin-catechin binary complex solution in step B, wherein the dextran solution and silk fibroin-catechin binary complex solution The volume ratio is 4:1, and the color of the magnetically stirred solution is uniform under the condition of a water bath at 46°C, and there is no layering.

实施例5Example 5

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将丝素蛋白粉末、儿茶素粉末和右旋糖酐粉末各自溶于去离子水中,分别得到浓度为8.0wt.%的丝素蛋白溶液;浓度为0.45wt.%的儿茶素溶液;浓度为5.0wt.%的右旋糖酐溶液;A. Stock solution preparation: dissolve silk fibroin powder, catechin powder and dextran powder in deionized water respectively to obtain a silk fibroin solution with a concentration of 8.0wt.%; a catechin solution with a concentration of 0.45wt.% ; Concentration is 5.0wt.% dextran solution;

B、丝素蛋白-儿茶素二元复合物的合成:将A步配置的丝素蛋白溶液和儿茶素溶液按照1:1的比例加入反应器,并在45℃的水浴条件下磁力搅拌2h,得到丝素蛋白-儿茶素二元复合物溶液;B. Synthesis of silk fibroin-catechin binary complex: add the silk fibroin solution and catechin solution prepared in step A into the reactor at a ratio of 1:1, and stir magnetically in a water bath at 45°C 2h, obtain the silk fibroin-catechin binary complex solution;

C、凝胶的制备:将A步配置的右旋糖酐溶液加入到B步的丝素蛋白-儿茶素二元复合物溶液中,其中右旋糖酐溶液与丝素蛋白-儿茶素二元复合物溶液的体积比为2:1,在50℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C. Preparation of gel: Add the dextran solution configured in step A to the silk fibroin-catechin binary complex solution in step B, wherein the dextran solution and silk fibroin-catechin binary complex solution The volume ratio is 2:1, and the color of the magnetically stirred solution is uniform under the condition of a water bath at 50°C, and there is no layering.

实施例6Example 6

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将透明质酸粉末、没食子酸粉末和琼脂糖粉末各自溶于去离子水中,分别得到浓度为4.0wt.%的透明质酸溶液;浓度为0.75wt.%的没食子酸溶液;浓度为2.0wt.%的琼脂糖溶液;A. Stock solution preparation: respectively dissolve hyaluronic acid powder, gallic acid powder and agarose powder in deionized water to obtain a hyaluronic acid solution with a concentration of 4.0wt.% and a gallic acid solution with a concentration of 0.75wt.%. Concentration is 2.0wt.% agarose solution;

B、透明质酸-没食子酸二元复合物的合成:将A步配置的透明质酸溶液和没食子酸溶液按照6:1的比例加入反应器,并在48℃的水浴条件下磁力搅拌2h,得到透明质酸-没食子酸二元复合物溶液;B. Synthesis of hyaluronic acid-gallic acid binary complex: Add the hyaluronic acid solution and gallic acid solution prepared in step A into the reactor at a ratio of 6:1, and magnetically stir for 2 hours in a water bath at 48°C. Obtain hyaluronic acid-gallic acid binary complex solution;

C、凝胶的制备:将A步配置的琼脂糖溶液加入到B步的透明质酸-没食子酸二元复合物溶液中,其中琼脂糖溶液与透明质酸-没食子酸二元复合物溶液的体积比为3:1,在42℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C, preparation of the gel: the agarose solution configured in step A is added to the hyaluronic acid-gallic acid binary complex solution of step B, wherein the agarose solution and the hyaluronic acid-gallic acid binary complex solution The volume ratio is 3:1, and the color of the magnetically stirred solution is uniform under the condition of a water bath at 42°C, and there is no layering.

实施例7Example 7

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将透明质酸及胶原粉末、鞣花酸粉末和亚麻籽胶粉末各自溶于去离子水中,分别得到浓度为3.0wt.%的透明质酸及胶原溶液;浓度为0.5wt.%的鞣花酸溶液;浓度为5.0wt.%的亚麻籽胶溶液;A, stock solution preparation: respectively dissolve hyaluronic acid and collagen powder, ellagic acid powder and linseed gum powder in deionized water, and obtain the hyaluronic acid and collagen solution that concentration is 3.0wt.% respectively; Concentration is 0.5wt. % ellagic acid solution; concentration is 5.0wt.% linseed gum solution;

B、透明质酸及胶原-鞣花酸二元复合物的合成:将A步配置的透明质酸及胶原溶液和鞣花酸溶液按照6:1的比例加入反应器,并在40℃的水浴条件下磁力搅拌3h,得到透明质酸及胶原-鞣花酸二元复合物溶液;B. Synthesis of hyaluronic acid and collagen-ellagic acid binary complex: Add the hyaluronic acid, collagen solution and ellagic acid solution prepared in step A into the reactor at a ratio of 6:1, and put them in a water bath at 40°C Under the condition of magnetic stirring for 3 hours, the solution of hyaluronic acid and collagen-ellagic acid binary complex is obtained;

C、凝胶的制备:将A步配置的亚麻籽胶溶液加入到B步的透明质酸及胶原-鞣花酸二元复合物溶液中,其中亚麻籽胶溶液与透明质酸及胶原-鞣花酸二元复合物溶液的体积比为2:1,在40℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C. Preparation of gel: Add the linseed gum solution configured in step A to the hyaluronic acid and collagen-ellagic acid binary complex solution in step B, wherein the linseed gum solution is mixed with hyaluronic acid and collagen-tanned The volume ratio of the flower acid binary complex solution is 2:1, and the color of the solution is uniform under magnetic stirring in a water bath at 40°C without stratification.

实施例8Example 8

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将胶原粉末、熊苷果及花青素的混合粉末和海藻酸钠粉末各自溶于去离子水中,分别得到浓度为3.0wt.%的胶原溶液;浓度为0.5wt.%的熊苷果和花青素的混合溶液;浓度为5.0wt.%的海藻酸钠溶液;A, stock solution preparation: the mixed powder of collagen powder, arginin fruit and anthocyanin and sodium alginate powder are dissolved in deionized water respectively, obtain the collagen solution that concentration is 3.0wt.% respectively; Concentration is 0.5wt.% Arginin fruit and A mixed solution of anthocyanins; a sodium alginate solution with a concentration of 5.0wt.%;

B、胶原-熊苷果及花青素二元复合物的合成:将A步配置的胶原溶液与熊苷果和花青素的混合溶液按照6:1的比例加入反应器,并在40℃的水浴条件下磁力搅拌3h,得到胶原-熊苷果和花青素二元复合物溶液;B. Synthesis of collagen-arginin fruit and anthocyanin binary complex: Add the collagen solution prepared in step A and the mixed solution of arginin fruit and anthocyanin in a ratio of 6:1 to the reactor, and put them in a water bath at 40°C Magnetically stirred for 3 hours to obtain a collagen-arginin and anthocyanin binary complex solution;

C、凝胶的制备:将A步配置的海藻酸钠溶液加入到B步的胶原-熊苷果及花青素二元复合物溶液中,其中海藻酸钠溶液与胶原-熊苷果和花青素二元复合物溶液的体积比为2:1,在40℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C. Preparation of gel: Add the sodium alginate solution configured in step A to the collagen-arginin and anthocyanin binary complex solution in step B, wherein the sodium alginate solution is mixed with collagen-arginin and anthocyanin binary The volume ratio of the complex solution is 2:1, and the color of the solution is uniform under magnetic stirring under the condition of a water bath at 40° C. without stratification.

实施例9Example 9

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将明胶粉末、熊苷果粉末和壳聚糖粉末各自溶于去离子水中,分别得到浓度为3.0wt.%的明胶溶液;浓度为0.5wt.%的熊苷果溶液;浓度为5.0wt.%的壳聚糖溶液;A, stoste preparation: gelatin powder, arginin fruit powder and chitosan powder are dissolved in deionized water respectively, and concentration is respectively obtained the gelatin solution of 3.0wt.%; Concentration is the arginin fruit solution of 0.5wt.%; Concentration is 5.0wt. % chitosan solution;

B、明胶-熊苷果二元复合物的合成:将A步配置的明胶溶液与熊苷果溶液按照6:1的比例加入反应器,并在40℃的水浴条件下磁力搅拌3h,得到明胶-熊苷果二元复合物溶液;B. Synthesis of gelatin-arginin binary compound: add the gelatin solution and arginin solution prepared in step A into the reactor at a ratio of 6:1, and stir magnetically for 3 hours in a water bath at 40°C to obtain the gelatin-arginin binary compound Complex solution;

C、凝胶的制备:将A步配置的壳聚糖溶液加入到B步的明胶-熊苷果二元复合物溶液中,其中壳聚糖溶液与明胶-熊苷果二元复合物溶液的体积比为2:1,在40℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C, preparation of gel: the chitosan solution configured in step A is added in the gelatin-arginin binary complex solution of B step, wherein the volume ratio of chitosan solution and gelatin-arginin binary compound solution is 2 : 1, under the condition of 40 DEG C of water bath, the magnetically stirred solution has uniform color and no stratification, to obtain final product.

实施例10Example 10

一种用于3D生物打印的可触变性水凝胶的制备方法,包括以下步骤:A method for preparing a thixotropic hydrogel for 3D bioprinting, comprising the following steps:

A、原液配制:将胶原粉末、花青素粉末和结冷胶粉末各自溶于去离子水中,分别得到浓度为3.0wt.%的胶原溶液;浓度为0.5wt.%的花青素的混合溶液;浓度为5.0wt.%的结冷胶溶液;A. Stock solution preparation: Dissolve collagen powder, anthocyanin powder and gellan gum powder in deionized water respectively to obtain a collagen solution with a concentration of 3.0wt.%; a mixed solution of anthocyanins with a concentration of 0.5wt.% ; Concentration is 5.0wt.% gellan gum solution;

B、胶原-花青素二元复合物的合成:将A步配置的胶原溶液和花青素溶液按照10:1的比例加入反应器,并在45℃的水浴条件下磁力搅拌2h,得到胶原-花青素二元复合物溶液;B. Synthesis of collagen-anthocyanin binary complex: Add the collagen solution and anthocyanin solution prepared in step A into the reactor at a ratio of 10:1, and stir magnetically for 2 hours in a water bath at 45°C to obtain collagen - anthocyanin binary complex solution;

C、凝胶的制备:将A步配置的结冷胶溶液加入到B步的胶原-花青素二元复合物溶液中,其中结冷胶溶液与胶原-花青素二元复合物溶液的体积比为2:1,在50℃的水浴条件下磁力搅拌溶液颜色均一,且不分层,即得。C, preparation of the gel: the gellan gum solution configured in step A is added to the collagen-anthocyanin binary complex solution in step B, wherein the gellan gum solution and the collagen-anthocyanin binary complex solution The volume ratio is 2:1, and the color of the magnetically stirred solution is uniform under the condition of a water bath at 50°C, and there is no layering.

Claims (3)

1. A preparation method of thixotropic hydrogel for 3D bioprinting comprises the following steps:
A. preparing stock solution: dissolving protein powder, polyphenol powder and polysaccharide powder in deionized water respectively to obtain protein solutions with the concentration of 3.0-10.0 wt.%; a polyphenol solution having a concentration of 0.10-0.75 wt.%; a polysaccharide solution having a concentration of 2.0-8.0 wt.%;
the polysaccharide is sodium alginate, chitosan, gellan gum, dextran, agarose or flaxseed gum;
B. synthesis of protein-polyphenol binary complex: adding the protein solution and the polyphenol solution prepared in the step A into a reactor according to the proportion of 1-10 to 1, and magnetically stirring for 1-3 hours under the water bath condition of 40-50 ℃ to obtain a protein-polyphenol binary compound solution;
C. preparation of gel: and (3) adding the polysaccharide solution prepared in the step (A) into the protein-polyphenol binary compound solution prepared in the step (B), wherein the volume ratio of the polysaccharide solution to the protein-polyphenol binary compound solution is 2-4.
2. The method of preparing the thixotropic hydrogel for 3D bioprinting according to claim 1, wherein: the protein in the step A is a mixture of more than one of gelatin, fibrinogen, fibrin, silk fibroin or collagen.
3. The method of preparing the thixotropic hydrogel for 3D bioprinting according to claim 1, wherein: the polyphenol in the step A is a mixture of more than one of tannin, tea polyphenol, caffeic acid, gallic acid, ellagic acid, arbutin or anthocyanin.
CN202010144190.XA 2020-03-04 2020-03-04 A preparation method of thixotropic hydrogel for 3D bioprinting Active CN111320767B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010144190.XA CN111320767B (en) 2020-03-04 2020-03-04 A preparation method of thixotropic hydrogel for 3D bioprinting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010144190.XA CN111320767B (en) 2020-03-04 2020-03-04 A preparation method of thixotropic hydrogel for 3D bioprinting

Publications (2)

Publication Number Publication Date
CN111320767A CN111320767A (en) 2020-06-23
CN111320767B true CN111320767B (en) 2023-01-10

Family

ID=71169235

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010144190.XA Active CN111320767B (en) 2020-03-04 2020-03-04 A preparation method of thixotropic hydrogel for 3D bioprinting

Country Status (1)

Country Link
CN (1) CN111320767B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113230017A (en) * 2021-05-10 2021-08-10 上海捷儿金科技股份有限公司 Heat-insulating pad and application thereof
CN113244455B (en) * 2021-05-17 2022-08-05 广西医科大学 A kind of 3D printing flaxseed hydrogel scaffold and preparation method and application
CN114515353A (en) * 2022-02-23 2022-05-20 浙江卫未生物医药科技有限公司 Composite hydrogel based on umbilical cord stem cells and umbilical cord stem cell exosomes, and preparation method and application thereof
CN117567797B (en) * 2023-10-30 2025-03-14 渤海大学 Method for preparing liquid printing matter based on polysaccharide and aminated polydimethylsiloxane and application thereof
CN118079083B (en) * 2024-04-26 2024-06-21 上海埃度医疗器械科技有限公司 Low-rejection cartilage supporting material and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105034369A (en) * 2015-07-10 2015-11-11 青岛尤尼科技有限公司 Three-dimensional (3D) cornea stroma support material and method for constructing three-dimensional cornea stroma support
CN106999635A (en) * 2014-12-11 2017-08-01 苏黎世联邦理工学院 Repair of cartilage graft support and its manufacture method
CN107157806A (en) * 2017-05-27 2017-09-15 南方医科大学 It is a kind of suitable for gel-type vehicle of 3D printing facial mask and its preparation method and application
CN107950684A (en) * 2017-12-22 2018-04-24 暨南大学 A kind of oleogel rich in unrighted acid and preparation method and application
CN110124105A (en) * 2019-04-15 2019-08-16 杭州电子科技大学 The biological 3D printing ink-manufacturing method of controllable gel-sol phase transition temperature
CN110665063A (en) * 2019-10-28 2020-01-10 中国人民解放军第四军医大学 3D biological printing ink and preparation method thereof, tissue engineering scaffold and preparation method thereof
CN110790954A (en) * 2019-11-11 2020-02-14 上海黑焰医疗科技有限公司 A kind of preparation method of photocurable bio-ink

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101629204B1 (en) * 2014-08-19 2016-06-10 전북대학교산학협력단 Thin Film Silk fibroin/collagen composite implant and Preparation Method Thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106999635A (en) * 2014-12-11 2017-08-01 苏黎世联邦理工学院 Repair of cartilage graft support and its manufacture method
CN105034369A (en) * 2015-07-10 2015-11-11 青岛尤尼科技有限公司 Three-dimensional (3D) cornea stroma support material and method for constructing three-dimensional cornea stroma support
CN107157806A (en) * 2017-05-27 2017-09-15 南方医科大学 It is a kind of suitable for gel-type vehicle of 3D printing facial mask and its preparation method and application
CN107950684A (en) * 2017-12-22 2018-04-24 暨南大学 A kind of oleogel rich in unrighted acid and preparation method and application
CN110124105A (en) * 2019-04-15 2019-08-16 杭州电子科技大学 The biological 3D printing ink-manufacturing method of controllable gel-sol phase transition temperature
CN110665063A (en) * 2019-10-28 2020-01-10 中国人民解放军第四军医大学 3D biological printing ink and preparation method thereof, tissue engineering scaffold and preparation method thereof
CN110790954A (en) * 2019-11-11 2020-02-14 上海黑焰医疗科技有限公司 A kind of preparation method of photocurable bio-ink

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A cell-printing approach for obtaining hASC-laden scaffolds by using a collagen/polyphenol bioink;Yeo, Myung Gu et al.;《BIOFABRICATION》;20170412;2页实验部分、附图1 *
丝素蛋白水凝胶的凝胶机理及改性方法研究进展;刘迪等;《蚕业科学》;20180215(第01期);全文 *

Also Published As

Publication number Publication date
CN111320767A (en) 2020-06-23

Similar Documents

Publication Publication Date Title
CN111320767B (en) A preparation method of thixotropic hydrogel for 3D bioprinting
Ren et al. Developments and opportunities for 3D bioprinted organoids
Yang et al. Stem cell-laden hydrogel-based 3D bioprinting for bone and cartilage tissue engineering
Donderwinkel et al. Bio-inks for 3D bioprinting: recent advances and future prospects
Mehrban et al. 3D bioprinting for tissue engineering: Stem cells in hydrogels
Guo et al. Biomacromolecules for tissue engineering: emerging biomimetic strategies
Xiaorui et al. Biomaterial inks for extrusion-based 3D bioprinting: Property, classification, modification, and selection
US20190209738A1 (en) Preparation and applications of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks to control cellular fate processes such as adhesion, proliferation and differentiation
Yang et al. Advanced strategies in the application of gelatin-based bioink for extrusion bioprinting
CN104892962A (en) Preparation method and application of sulfhydryl/disulfide bond controllable self-crosslinked hyaluronic acid hydrogel
CN112533652A (en) Nanocellulose-containing bio-ink for 3D bio-printing, methods of making and using the same, and 3D biological structures obtained thereby
CN110859994B (en) A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof
CN110743041A (en) Photocurable enzyme cross-linked bioink and its preparation method and 3D printing method
CN113150561B (en) Collagen-based biological ink for 3D biological printing and preparation method and application thereof
Camacho et al. Materials as bioinks and bioink design
Costa et al. Towards biologically relevant synthetic designer matrices in 3D bioprinting for tissue engineering and regenerative medicine
Tamay et al. Bioinks—materials used in printing cells in designed 3D forms
Wang et al. Cryoprinting of nanoparticle-enhanced injectable hydrogel with shape-memory properties
Shuai et al. Bioengineered silk protein‐based 3D in vitro models for tissue engineering and drug development: from silk matrix properties to biomedical applications
He et al. Recent advancements of bioinks for 3D bioprinting of human tissues and organs
CN112999428B (en) Three-dimensional bioprinting ink for auricle reconstruction with cell-loaded polymer porous microspheres and its manufacturing method and application
Zheng et al. Advancing cardiac regeneration through 3D bioprinting: methods, applications, and future directions
Wang et al. Engineered living systems based on gelatin: design, manufacturing, and applications
CN108310463A (en) 3D printing biological ink and preparation method thereof
KR20220034646A (en) A preparation method of extracellular vesicles with cellular spheroid and extracellular vesicles made thereby

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant